A Study of a Behavioral Intervention for Both Cigarette Smoking and Binge Drinking in Young Adults

Overview

About this study

 Nicotine patches and behavioral therapy may help reduce cigarette smoking and binge drinking in young adults.This randomized clinical trial studies nicotine patches with or without behavioral therapy in reducing cigarette smoking and binge drinking in young adults.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

This study has been completed

Inclusion Criteria     

  • Age 18–30 years
  • Smoked an average of greater than or equal to 1 or more cigarettes per day during the past 6 months
  • Binge drank on an average of  > 1 occasions per month during the past 3 months
    • Binge drinking is defined as consumption of > 5 standardized alcoholic drinks in a row for males or > 4  drinks in a row for females
  • Able to participate fully in all aspects of the intervention and keep all scheduled appointments
  • Willing to participate in 6 months of follow-up
  • Willing to stop smoking and use nicotine patch therapy
  • Willing to refrain from participating in additional smoking interventions for the duration of the study
  • Provide written informed consent.

Exclusion Criteria:      

  • Current (past 90 days) alcohol dependence as assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders, Alcohol Dependence Module
  • Current (past 12 months) non-nicotine or alcohol drug dependence as assessed by a Drug Abuse Screening Test-20 score of > 6
  • Current elevation of depressive symptoms (past 2 weeks) that would be indicative of clinical depression as assessed by a Beck Depression Inventory-II score of > 20
  • Current use (past 30 days) of nicotine containing medication or frequent use (> 10 occasions per month) of tobacco products other than cigarettes
  • Current use (past 30 days) of any other smoking cessation treatment involving behavioral or pharmacological interventions
  • Any medical condition that would preclude use of the nicotine patch including
    • current unstable angina
    • recent history (past 30 days) of myocardial infarction or stroke
    • history of severe skin allergies
    • evidence of severe chronic dermatosis
  • Currently pregnant or breast feeding, or likely to become pregnant during the nicotine patch phase
  • A member of the household has participated in the trial

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Steven Ames, Ph.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20315195

Mayo Clinic Footer